About REVATIO® (sildenafil) | Safety Info

Why Revatio

For almost 15 years, brand-name REVATIO has helped treat pulmonary arterial hypertension (PAH) in adults. If you have PAH, ask your doctor about moving forward with brand-name REVATIO–only from Pfizer.

REVATIO is clinically proven

  • In a clinical study of 267 PAH patients, REVATIO taken with epoprostenol:

  • Increased the distance people walked in a 6-minute defined time

  • Decreased pressure in the pulmonary artery

  • Helped lessen symptoms of PAH§

  • Helped slow down worsening changes in physical condition||

All patients continued intravenous epoprostenol therapy.

Patients on REVATIO achieved a statistically important reduction in mPAP vs placebo.

§Measured by improvements in WHO functional class (classifies patients based on limitations of physical activity and symptoms).

||REVATIO patients had a significant delay to clinical worsening and were less likely to experience clinical worsening (death, lung transplantation, initiation of bosentan, or clinical deterioration) vs placebo.

Revatio is the brand you recognize

  • The REVATIO pill has a distinctive shape and marking to let you know you're getting the brand-name medication—pill to pill, month to month

  • Brand-name REVATIO is from a company you know—only from Pfizer

  • You have the assurance that Pfizer stands behind its manufacturing standards

Revatio Pills

Revatio Offers Savings To Patients

If eligible, patients may pay as little as $0 each month for brand-name REVATIO—and could save up to $12,000 a year.*


You Are Leaving Revatio.com

Links to another site are provided as a convenience to the viewer.

Pfizer accepts no responsibility for the content of linked sites.


You Are Leaving Revatio.com

The information provided in REVATIOHCP.com is intended only for healthcare professionals in the United States.